血管介入治疗在肝癌综合治疗中应用与评价

Application and evaluation of vascular interventional therapy in multidisciplinary treatment for hepatocellular carcinoma

血管介入治疗是肝癌介入治疗应用最早、使用范围最广的微创治疗技术,包括传统的肝动脉化疗栓塞术、改良的肝动脉栓塞术、肝动脉灌注化疗以及门静脉、肝静脉癌栓腔内治疗。掌握好肝癌血管介入的个体化治疗能收到很好的临床疗效。近年来治疗肝动脉栓塞的新药物的出现进一步提高了肝动脉化疗栓塞术的安全性及疗效。尽管血管介入临床疗效显著,但仍须结合病人情况联合非血管介入及多学科综合治疗,以进一步提高疗效和减少副反应。

Vascular interventional radiology,which includes conventional transarterial TACE,modified HAE/HAIC and vascular management of portal vein tumor thrombosis, is the earliest and widest used operation in treating hepatocellular carcinoma（HCC） minimal-invasively. Individualized treatment is a well effective modality in selected HCC patients. Furthermore, some neo-drugs for arterial embolization improve its safety and efficacy. Although many patients with advanced HCC did benefit from the vascular interventional therapy just due to their effective treatment in HCC, non-vascular interventional therapy and multidisciplinary treatment based on individual status still need to be performed for HCC.